SWKH Stock Overview
Offers specialty finance and asset management services in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for SWKH from our risk checks.
SWK Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$15.16 |
| 52 Week High | US$18.75 |
| 52 Week Low | US$15.15 |
| Beta | 0.36 |
| 11 Month Change | -8.95% |
| 3 Month Change | -12.01% |
| 1 Year Change | -7.73% |
| 33 Year Change | -21.04% |
| 5 Year Change | 18.44% |
| Change since IPO | -99.41% |
Recent News & Updates
Recent updates
SWK Holdings: Baby Bond Represents Only Debt And 8.9% Coupon Yield
Sep 19SWK Holdings Offers Attractive 9% Baby Bond
Apr 09SWK Holdings unit receives $5M payment from Cara Therapeutics
Oct 10SWK Holdings announces leadership transition
Sep 01Killer R2K Setup In SWK
Apr 27Shareholders May Be More Conservative With SWK Holdings Corporation's (NASDAQ:SWKH) CEO Compensation For Now
Jun 11
Update: SWK Holdings (NASDAQ:SWKH) Stock Gained 46% In The Last Five Years
Feb 16
Here's What SWK Holdings Corporation's (NASDAQ:SWKH) Shareholder Ownership Structure Looks Like
Jan 12Enteris Biopharma sees growth opportunities in 2021 with potential partnerships in the works
Jan 07SWK Holdings' subsidiary receives second milestone payment from Cara
Dec 24A Look At SWK Holdings' (NASDAQ:SWKH) CEO Remuneration
Dec 08SWK Holdings EPS beats by $0.40, beats on revenue
Nov 13Shareholder Returns
| SWKH | US Diversified Financial | US Market | |
|---|---|---|---|
| 7D | -8.8% | -0.3% | -1.0% |
| 1Y | -7.7% | 30.9% | 30.3% |
Return vs Industry: SWKH underperformed the US Diversified Financial industry which returned 32.4% over the past year.
Return vs Market: SWKH underperformed the US Market which returned 30.4% over the past year.
Price Volatility
| SWKH volatility | |
|---|---|
| SWKH Average Weekly Movement | 2.5% |
| Diversified Financial Industry Average Movement | 5.1% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: SWKH has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: SWKH's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 22 | Joe Staggs | www.swkhold.com |
SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.
SWK Holdings Corporation Fundamentals Summary
| SWKH fundamental statistics | |
|---|---|
| Market cap | US$187.90m |
| Earnings (TTM) | US$10.46m |
| Revenue (TTM) | US$24.73m |
17.7x
P/E Ratio7.5x
P/S RatioIs SWKH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SWKH income statement (TTM) | |
|---|---|
| Revenue | US$24.73m |
| Cost of Revenue | US$2.24m |
| Gross Profit | US$22.49m |
| Other Expenses | US$12.03m |
| Earnings | US$10.46m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.86 |
| Gross Margin | 90.95% |
| Net Profit Margin | 42.31% |
| Debt/Equity Ratio | 11.0% |
How did SWKH perform over the long term?
See historical performance and comparison